Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy

NCT05342857 is registered in ClinicalTrials.gov with Shin Kong Wu Ho-Su Memorial Hospital as lead sponsor.

NCT NCT05342857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05342857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy
Lead sponsor
Shin Kong Wu Ho-Su Memorial Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
April 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration